These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 11498161

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of tacrolimus on the outcome of renal transplantation with donor-specific blood transfusion.
    Miura S, Okazaki H, Sato T, Amada N, Ohashi Y.
    Transplant Proc; 1998 Jun; 30(4):1212-3. PubMed ID: 9636492
    [No Abstract] [Full Text] [Related]

  • 4. Long-term graft survival of living-related kidneys after donor-specific transfusion.
    Otsuka M, Yuzawa K, Takada Y, Taniguchi H, Fukunaga K, Seino K, Todoroki T, Fukao K.
    Transplant Proc; 2000 Nov; 32(7):1741-2. PubMed ID: 11119914
    [No Abstract] [Full Text] [Related]

  • 5. Prophylactic use of deoxyspergualin improves long-term graft survival in living related renal transplant recipients transfused with donor-specific blood.
    Amada N, Okazaki H, Sato T, Miura S, Ohashi Y.
    Transplant Proc; 2001 May; 33(3):2256-7. PubMed ID: 11377520
    [No Abstract] [Full Text] [Related]

  • 6. Kidney transplantation from older ( > or = 55 years) donors: a risk factor for graft survival.
    Mizutani K, Katoh N, Yamada S, Ono Y, Takeuchi N, Matsuura O, Ohshima S.
    Transplant Proc; 1996 Jun; 28(3):1589-90. PubMed ID: 8658797
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunosuppression protocols for HLA identical renal transplant recipients.
    Keitel E, Santos AF, Alves MA, Neto JP, Schaefer PG, Bittar AE, Goldani JC, Pozza R, Bruno RM, See D, Garcia CD, Garcia VD.
    Transplant Proc; 2003 May; 35(3):1074-5. PubMed ID: 12947863
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ, Roy G, Reynolds L, Corwin C, Hunsicker L.
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract] [Full Text] [Related]

  • 15. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee.
    Hardie IR, Tiller DJ, Mahony JF, Miach PJ, Thomson NM, Thatcher GN, Rigby RJ, Menzies BL.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424
    [No Abstract] [Full Text] [Related]

  • 16. Effect of anti CD45 on different immunosuppressive regimes in renal transplantation.
    Talbot D, Shenton BK, Bell A, White M, Glennon A, Manas D, Minford E, Rix D, Mathew A, Kumar A, Taylor RM.
    Transplant Proc; 1996 Dec; 28(6):3212-3. PubMed ID: 8999605
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of long-term results in kidney transplantation performed using a rejection-free protocol with cyclosporine and thoracic duct drainage.
    Kinukawa T, Ono Y, Takeuchi N, Hattori R, Ohshima S.
    Transplant Proc; 1997 Dec; 29(1-2):946-7. PubMed ID: 9123600
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.